Neal E. Dunlap, M.D. — School of ...

Dr. Neal E. Dunlap

Claim this profile

The James Graham Brown Cancer Center at University of Louisville

Studies Squamous Cell Carcinoma
Studies Lung Cancer
19 reported clinical trials
45 drugs studied

Area of expertise

1Squamous Cell Carcinoma
Neal E. Dunlap has run 5 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
p16 negative
Stage II
Stage I
2Lung Cancer
Neal E. Dunlap has run 4 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage I
Stage II

Affiliated Hospitals

Image of trial facility.
The James Graham Brown Cancer Center At University Of Louisville
Image of trial facility.
UofL Health Medical Center Northeast

Clinical Trials Neal E. Dunlap is currently running

Image of trial facility.

Pembrolizumab + Radiation vs Chemotherapy + Radiation

for Head and Neck Cancer

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
Image of trial facility.

Sentinel Lymph Node Biopsy vs Neck Dissection

for Oral Cancer

This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavity cancer. Sentinel lymph node biopsy surgery is a procedure that removes a smaller number of lymph nodes from your neck because it uses an imaging agent to see which lymph nodes are most likely to have cancer. Standard neck dissection, such as elective neck dissection, removes many of the lymph nodes in your neck. Using sentinel lymph node biopsy surgery may work better in treating patients with early-stage oral cavity cancer compared to standard elective neck dissection.
Recruiting1 award Phase 2 & 3

More about Neal E. Dunlap

Clinical Trial Related4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 13 Active Clinical Trials
Treatments Neal E. Dunlap has experience with
  • Cisplatin
  • Intensity-Modulated Radiation Therapy
  • Docetaxel
  • Carboplatin
  • Atezolizumab
  • Pembrolizumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Neal E. Dunlap specialize in?
Is Neal E. Dunlap currently recruiting for clinical trials?
Are there any treatments that Neal E. Dunlap has studied deeply?
What is the best way to schedule an appointment with Neal E. Dunlap?
What is the office address of Neal E. Dunlap?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security